Randomized, double-blinded, placebo-controlled trial of allogeneic cord blood T-regulatory cells for treatment of COVID-19 ARDS
Gladstone et al., Blood Advances, doi:10.1182/bloodadvances.2022009619
https://c19early.org/gladstone.html